Rt Hon JACINDA ARDERN: Again, the member completely—completely—misrepresents the process for purchasing vaccines. As I said, we began discussions with Pfizer in July of 2020. In August, we had a purchasing payment. In September, Pfizer presented to our research panel, and we made our first logistics call with the Ministry of Health. We signed an advanced purchase agreement in October of 2020 before Pfizer even completed their phase 3 trial. Again, so many times in this House we've tried to correct the member. I cannot help the member if she does not understand the process for the purchasing of pharmaceuticals in this country.